These results are in agreement with a previous study using intramyocardial injection of anti-TXNIP siRNA in the context of diabetes, which reduces oxidative stress, apoptosis and ischemia-induced myocardial damage [216]. The gene discussed is TXNIP; the disease is diabetes mellitus.